Jacques Rachelle Suzanne 4
4 · Akari Therapeutics Plc · Filed Apr 30, 2024
Insider Transaction Report
Form 4
Jacques Rachelle Suzanne
DirectorChief Executive Officer
Transactions
- Award
Ordinary Shares, par value $0.0001 per share
2024-04-26+479,569,892→ 1,018,027,792 total
Footnotes (1)
- [F1]These shares represent restricted stock units ("RSUs"), with each such RSU representing the right to receive one ordinary share, par value $0.0001. 50% of the RSUs shall vest on March 28, 2025, with the remainder vesting in 12 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.